Pharmaceutical Quality Management Systems Market Size & Share 2023 to 2032
Market Size by Solution Type (Regulatory & Compliance Management, Document Management, Audit Management), Deployment Model (Cloud-based), Enterprise Size (Large Enterprise), Global Forecast.
Report ID: GMI6226
|
Published Date: July 2023
|
Report Format: PDF
Download Free PDF
Authors:
Monali Tayade, Jignesh Rawal
Pharmaceutical Quality Management Systems Market Size
Pharmaceutical Quality Management Systems Market size accounted for USD 1.4 billion in 2022 and is estimated to grow at 13.1% to reach USD 4.5 billion by 2032 due to the increasing cost of drugs manufacturing.
Pharmaceutical Quality Management Systems Market Key Takeaways
Market Size & Growth
Key Market Drivers
Challenges
With the growing demand for high-quality drugs and an increasing awareness pertaining to the importance of quality in healthcare, pharmaceutical companies are prioritizing quality management systems to ensure patient safety and maintain high standards. Also, in the face of increasing cost pressures, quality management systems present pharmaceutical companies with a valuable solution for enhancing operational efficiency and decreasing expenses.
Pharmaceutical quality management systems (QMS) refer to a set of processes, procedures, and resources implemented by pharmaceutical companies to ensure the quality, safety, and efficacy of their products. These systems are designed to comply with regulatory requirements and industry standards throughout the entire product lifecycle, from research and development to manufacturing, distribution, and post-market surveillance.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the pharmaceutical quality management systems (QMS) market. As the global healthcare industry faced unprecedented challenges, pharmaceutical manufacturers increasingly recognized the significance of maintaining high-quality standards. This led to a heightened demand for robust QMS solutions to ensure the safety, efficacy, and quality of drugs and medical products. Furthermore, the adoption of quality management systems helped companies to enhance their quality management processes, implement risk mitigation strategies, and ensure compliance with rapidly changing regulations.
Pharmaceutical Quality Management Systems Market Trends
Increasing demand to comply with regulatory requirements is one of the significant progression drivers for the market. Pharmaceutical industries are subject to strict regulations, owing to the direct impact of drugs, medical devices, and medications on consumer health. Moreover, small, and mid-sized pharmaceutical businesses are concentrating on following laws to produce better products and maintain their competitiveness in the business.
Pharmaceutical Quality Management Systems Restraint
High implementation and maintenance costs may hamper the pharmaceutical quality management systems market development. Implementing a QMS solution involves expenses related to software licensing, customization, training, and integration with existing infrastructure. Additionally, ongoing maintenance costs include system upgrades, technical support, and regular updates to comply with evolving regulatory requirements. These costs can be burdensome for smaller pharmaceutical companies or those with limited budgets.
Pharmaceutical Quality Management Systems Solution Type Segmentation
By solution type, the pharmaceutical quality management systems market is classified into regulatory & compliance management, document management, supplier quality management, corrective action preventive action (CAPA) management, audit management, change management, training management, complaints management, non-conformances handling, inspection management, and other solution types. The regulatory & compliance management segment accounted for 18.7% of the market share in 2022. The regulatory & compliance management solutions empower pharmaceutical companies to streamline their regulatory processes, enhance data integrity, and minimize the possibility of non-compliance. Also, these solutions offer a centralized platform for efficiently managing tasks associated with regulatory and compliance requirements, including activities such as change management, document control, audit management, and deviation management.
Pharmaceutical Quality Management Systems Market Analysis
Based on deployment model, the pharmaceutical quality management systems market is segmented into cloud-based and on-premise. The cloud-based segment is expected to register around USD 2 billion by 2032. The cloud-based deployment model provides considerable advantages compared to traditional on-premises software or paper-based systems. The cloud-based technology simplifies the transition to an electronic QMS and enables remote access within a highly secure environment. Additionally, the model offers easy scalability, allowing businesses to increase the number of users and storage in response to changing business requirements.
Based on enterprise size, the pharmaceutical quality management systems market is segmented into large enterprise and small & medium enterprise (SME). The large enterprise segment accounted for 62% of the market share in 2022. Extensive operations, complex supply chains, and stringent compliance requirements in large enterprises will contribute to the industry gains. Furthermore, large enterprises often operate globally, making it crucial to have comprehensive quality management systems in place to ensure compliance across multiple jurisdictions.
North America pharmaceutical quality management systems market accounted for 42.3% market share in 2022. The region's well-established pharmaceutical industry, rigorous regulatory framework, and emphasis on quality standards will drive the demand for pharmaceutical quality management systems. For instance, in January 2021, Arena Solutions, Inc. partnered with Rimsys Inc., a developer of regulatory information management (RIM) software platforms to offer an end-to-end quality and product-centric regulatory solution. This partnership helped the company to expand its product offering.
Pharmaceutical Quality Management Systems Market Share
Major market players operating in the pharmaceutical quality management systems market include :
Pharmaceutical Quality Management Systems Industry News:
The pharmaceutical quality management systems market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:
Click here to Buy Section of this Report
By Solution Type
By Deployment Model
By Enterprise Size
The above information is provided for the following regions and countries:
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Security & defense sector journals and trade press
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 30+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →